Forskningssamarbejde med Novartis - 243.000

Obtained 243,000 kr from Novartis Denmark to cover expenses of my investigator initiated phase II clinical trial entitled: “Comparison of Zometa Retention and Effect in Multiple Myeloma and Breast Cancer”